Wichmann, Johannes
Pitt, Catherine
Eccles, Samantha
Garnham, Alexandra L.
Li-Wai-Suen, Connie S. N. http://orcid.org/0000-0003-0529-0804
May, Rose
Allan, Elizabeth
Wilcox, Stephen
Herold, Marco J. http://orcid.org/0000-0001-7539-7581
Smyth, Gordon K. http://orcid.org/0000-0001-9221-2892
Monahan, Brendon J.
Thomas, Tim http://orcid.org/0000-0002-7623-8344
Voss, Anne K. http://orcid.org/0000-0002-3853-9381
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (1058892, 1003435, 1084248, 1084352, 1143612, 1160518, 1084248, 1084352, 1143612, 1160518, 1081421, 1176789)
Article History
Received: 28 April 2021
Revised: 24 June 2022
Accepted: 30 June 2022
First Online: 20 July 2022
Competing interests
: BJM and EA have received salary support from the Cancer Therapeutics CRC and have worked on a KAT5 drug discovery project for that organization. TT and AKV received funding for research from the CRC for Cancer Therapeutics and CTxOne, not for the project described here, but for research on other MYST family histone acetyltransferases. All other authors have no competing interest to declare.
: All animal experiments were approved by the Walter and Eliza Hall Institute Animal Ethics Committee and conducted in accordance with the Australian code of practice for the care and use of animals for scientific purposes.